Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)

P. Lorigan, J. Soria, J. Stephenson, A. Maru, R. Gervais, M. Zhu, I. McCaffery, Y. Jiang, J. McGreivy, B. Glisson

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)149-149
Number of pages1
JournalAnnals of Oncology
Issue numberSupplement 8
Publication statusPublished - Oct 2010
EventESMO 2010 Congress - Milan, Italy
Duration: 8 Oct 201012 Oct 2010

Cite this